Summary
β-catenin, a component of the E-cadherin–catenin cell adhesion complex, also plays a separate intracellular signalling role, interacting with APC protein. Intracellular accumulation of β-catenin is common in colorectal neoplasia. β-catenin abnormalities are associated with poor survival in gastric cancer, but previous studies do not differentiate between membrane-associated and intracellular β-catenin. In this study we aimed to determine which type of expression abnormalities for E-cadherin, β-catenin and α-catenin correlate with clinico-pathological features and survival in gastric cancer. Immunoperoxidase staining of paraffin-embedded sections from 40 gastric cancers was performed for E-cadherin, α- and β-catenins using microwave unmasking and an avidin–biotin technique. Clinical data were obtained from case records and cancer registry records. Reduced membranous expression of β-catenin occurred in 10/12 (83%) diffuse and 8/28 (29%) intestinal tumours (P = 0.0014), and was associated with poor differentiation (P = 0.0015) and short survival (P = 0.032), but not with age, sex, tumour size or nodal status. Nuclear expression of β-catenin was uncommon; cytoplasmic expression was observed in 13/40 cases (33%) but did not correlate with histology, tumour grade or survival. Reduced E-cadherin membrane expression was associated with lymph node metastasis (P = 0.02). Neither E-cadherin or α-catenin expression correlated with survival. Reduced membranous expression of β-catenin predicts poor prognosis in gastric cancer, whilst ectopic intracellular expression is relatively rare. The apparent differences in β-catenin expression from those found in colon cancer merit further study.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Becker, KF & Hofler, H (1995). Frequent somatic allelic inactivation of the E-cadherin gene in gastric carcinomas. J Natl Cancer Inst 87: 1082–1084.
Behrens, J, Kries, JP, Kuhl, M, Bruhn, L, Wedlich, D, Grosschedl, R & Birchmeier, W (1996). Functional interaction of β-catenin with the transcription factor LEF-1. Nature 382: 638–642.
Birchmeier, W & Behrens, J (1994). Cadherin expression in carcinomas – role in the formation of cell-junctions and the prevention of invasiveness. Biochim Biophys Acta Rev Cancer 1198: 11–26.
Bringuier, PP, Umbas, R, Schaafsma, HE, Karthus, HF, Debruyne, FM & Schalken, JA (1993). Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumours. Cancer Res 53: 3241–3248.
Buiatti, E, Palli, D & DeCarli, A et al (1989). A case–control study of gastric cancer and diet in Italy. Int J Cancer 44: 611–616.
Cancer Research Campaign (1993). Factsheet 18, Cancer Research Campaign: London
Clark, DJ, Scholefield, JH & Watson, SA (1999). Comparison of E-Cadherin and β-catenin expression in a mouse model of famalial adenomatous polyposis. Gut 44: A98
Eurogast Study Group (1994). An international association between Helicobacter pylori infection and gastric cancer. Lancet 34: 1359–1362.
Gabbert, HE, Meullers, W, Schneiders, A, Meier, S, Moll, R, Birchmeier, W & Hommel, G Prognostic value of E-cadherin expression in 413 gastric carcinomas. Int J Cancer 69: 184–189.
Guilford, P, Hopkins, J, Harraway, J, MacLeod, M & MacLeod, N et al (1998). E-cadherin germline mutations in familial gastric cancer. Nature 392: 402–405.
Hinck, L, Nelson, WJ & Papkoff, J (1994). WNT-1 modulates cell–cell adhesion in mammalian cells by stabilizing beta-catenin binding to the cell adhesion protein cadherin. J Cell Biol 124: 729–741.
Holstein, M, Sidransky, D, Vogelstein, B & Harris, CC (1991). p53 mutations in human cancers. Science 253: 49–53.
Hugh, TJ, Dillon, SA, Poston, GJ, Taylor, BA, Pignatelli, M & Kinsella, AN (1999). Cadherin-catenin expression in primary colorectal cancer: a survival analysis. Br J Cancer 80: 1046–1051.
Inomata, M, Ochiai, A, Akimoto, S, Kitano, S & Hirohashi, S (1996). Alteration of beta-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients. Cancer Res 56: 2213–2217.
Jawhari, A, Jordan, S, Poole, S, Browne, P, Pignatelli, M & Farthing, MJG (1997). Abnormal immunoreactivity of the E–cadherin–catenin complex in gastric cancer: relationship with patient survival. Gastroenterology 112: 46–54.
Kawanishi, J, Kato, J, Sasaki, K, Fujii, S, Watanabe, N & Niitsu, Y (1995). Loss of E-cadherin-dependent cell–cell adhesion due to mutation of the beta-catenin gene in a human cancer cell line, HSC-39. Mol Cell Biol 15: 1175–1181.
Korinek, V, Barker, N, Morin, PJ, Van Wichen, D, de Weger, R, Kinzler, KW, Vogelstein, B & Clevers, H (1997). Constitutive transcriptional activation by a β-catenin-Tcf complex in APC−/−colon carcinoma. Science 275: 1784–1787.
Krishnadath, KK, Tilanus, HW, van Blankenstein, M, Hop, WCJ, Kremers, ED, Dinjens, WNM & Bosman, FT (1997). Reduced expression of the cadherin–catenin complex in oesophageal adenocarcinoma correlates with poor prognosis. J Pathol 182: 331–338.
Lauren, P (1965). The two histological main types of gastric carcinoma. Acta Pathol Microbiol Scand 64: 31–49.
Maruyama, K & Miwa, K (1987). Japanese staging system for gastric cancer: evaluation and documentation of tumour extension. Scand J Gastroenterol 22: 22–26.
Matsui, S, Shiozaki, H, Inoue, M, Tamura, S, Doki, Y, Kadowaki, T, Iwazana, T, Shimaya, K, Nagafuchi, A, Tsukita, S & Mori, T (1994). Immunohistochemical evaluation of alpha-catenin in human gastric cancer. Virchows Archiv Int J Pathol 424: 375–381.
Matsuura, K, Kawanishi, J, Fujii, S, Imamura, M, Hirano, S, Takeichi, M & Niitsu, Y (1992). Altered expression of E-cadherin in gastric cancer tissue and carcinomatous fluid. Br J Cancer 66: 1122–1130.
Morin, PJ, Sparks, AB, Korinek, V, Barker, N, Clevers, H, Vogelstein, B & Kinzler, KW (1997). Activation of β-catenin-Tcf signalling in colon cancer by mutations in β-catenin or APC. Science 275: 1787–1790.
Munemitsu, S, Albert, I, Souza, B, Rubinfeld, B & Polakis, P (1995). Regulation of intracellular β-catenin levels by the adenomatous polyposis-coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 92: 3046–3050.
Nakatsuru, S, Yanagisawa, A, Ichii, S, Tahara, E, Kato, Y, Nakamura, Y & Horii, A (1992). Somatic mutations of the APC gene in gastric cancer: frequent mutations in very well-differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Gen 1: 559–563.
Nigam, AK, Savage, FJ, Boulos, PB, Stamp, GW, Liu, D & Pignatelli, M (1993). Loss of cell–cell and cell matrix adhesion molecules in colorectal cancer. Br J Cancer 68: 507–514.
Ochiai, T, Sasako, M, Mizuno, S, Kinoshita, T & Takayama, T et al (1994). Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors. Br J Surg 81: 1175–1178.
Oka, H, Shiozaki, H, Kobayashi, K, Tahara, H & Tamura, S et al (1992). Immunohistochemical evaluation of E-cadherin adhesion molecule expression in human gastric cancer. Virchows Arch [A] 421: 149–156.
Oka, H, Shiozaki, H, Kobayashi, K, Inoue, M, Tahara, E, Kobayashi, T, Takatsuka, Y, Matsuyoshi, N, Hirano, S & Takeichi, M (1993). Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res 53: 1696–1701.
Papkoff, J, Rubinfield, B, Schryver, B & Polakis, P (1996). Wnt-1 regulates free pools of catenins and stabilizes APC–catenin complexes. Mol Cell Biol 16: 2128–2134.
Pignatelli, M, Ansari, TW, Gunter, P, Liu, D, Hirano, S, Takeichi, M, Kloppel, G & Lemoine, NR (1994). Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade and advanced stage. J Pathol 174: 243–248.
Powell, SM, Zilz, N, Beazer-Barclay, Y, Bryan, TM, Hamilton, SR, Thibodeau, SN, Vogelstein, B & Kinzler, KW (1992). APC mutations occur early during colorectal tumorigenesis. Nature (Lond) 359: 235–237.
Rubinfeld, B, Souza, B, Albert, I, Muller, O, Chamberlain, SH, Masiarz, FR, Munimetsu, S & Polakis, P (1993). Association of the APC gene product with beta-catenin. Science 262: 1731–1734.
Rubinfeld, B, Souza, B, Albert, I, Munimetsu, S & Polakis, P (1995). The APC protein and cadherin form similar but independent complexes with alpha-catenin, beta-catenin and plakoglobulin. J Biol Chem 270: 5549–5555.
Shibamoto, S, Hayakawa, M, Takeuchi, K, Hori, T, Oku, N & Miyazawa, K et al (1994). Tyrosine phosphorylation of beta-catenin and plakoglobin enhanced by hepatocyte growth factor and epidermal growth factor in human carcinoma cells. Cell Adhesion Commun 1: 295–305.
Shimoyama, Y & Hirohashi, S (1991). Expression of E- and P-cadherin in gastric carcinoma. Cancer Res 51: 2185–2192.
Sobin LH, Wittekind C (1997). International Union against Cancer (UICC). TNM Classification of Malignant Tumours, 5th edn.Springer: Berlin
Streit, M, Schmidt, R, Hilgenfeld, RU & Thiel, E Kreuser (1996). Adhesion receptors in malignant transformation and dissemination of gastrointestinal tumors. J Mol Med 74: 253–268.
Tahara, E, Sumiyoshi, H, Hata, J, Yasui, W, Taniyama, K, Hayashi, T, Nagaye, S & Sakamoto, S (1986). Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy. Jpn J Cancer Res (Gann) 77: 145–152.
Takayama, T, Shiozaki, H, Doki, Y, Oka, H, Inoue, M, Yamamoto, M, Tamurs, S, Shibamoto, S, Ito, F & Monden, M (1998). Aberrant expression and phosphorylation of β-catenin in human colorectal cancer. Br J Cancer 77: 605–613.
Takeichi, M (1993). Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5: 806–811.
Umbas, R, Schalken, JA, Aalders, TW, Carter, BSm, Karthaus, HF, Schafsma, HE, Debruyue, FM & Isaacs, WB (1992). Expression of cellular adhesion molecule E-cadherin is reduced or absent in high grade prostate cancer. Cancer Res 52: 5104–5109.
Welch, JP & Donaldson, GA (1979). The clinical correlation of an autopsy study of recurrent colorectal cancer. Ann Surg 189: 496–502.
Whelan SL, Parkin DM, Masuyer E (1993). Trends in Cancer Incidence and Mortality, IARC Scientific Publications No. 102. IARC: Lyon
Yonemura, Y, Ninomiya, I, Kaji, M, Sugiyama, K & Fujimura, T et al (1995). Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Ann Cell Pathol 8: 177–190.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Ramesh, S., Nash, J. & McCulloch, P. Reduction in membranous expression of β-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer. Br J Cancer 81, 1392–1397 (1999). https://doi.org/10.1038/sj.bjc.6693437
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bjc.6693437
Keywords
This article is cited by
-
Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer
Scientific Reports (2020)
-
Epistemology of the origin of cancer: a new paradigm
BMC Cancer (2014)
-
Loss of vinculin and membrane-bound β-catenin promotes metastasis and predicts poor prognosis in colorectal cancer
Molecular Cancer (2014)
-
Expression of APC, β-catenin and E-cadherin in Tunisian patients with gastric adenocarcinoma: clinical significance
Tumor Biology (2014)
-
A novel CDH1 germline missense mutation in a sporadic gastric cancer patient in north-east of Italy
Clinical and Experimental Medicine (2013)